Sigilon Therapeutics, Inc. Transaction

Listed Equity Investment Deal in United States, North America

Transaction Details

Name:Sigilon Therapeutics, Inc.
Amount:Available on swfi.com
Announced At:06/29/2023
Closed At:06/29/2023
RegionNorth America
Country:United States
Type:Deal
Security Type:Ordinary Shares
Investment Type:Listed Equity
SectorHealthcare
Industry:Biotechnology
Summary:Available

Buyers

Entity 1
Pharmaceutical Company in United States		Stake
Available on swfi.com
  • 1 Legal Advisor